ArticleJournal of immunology research2018

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models.

Qing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.